Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease

被引:107
|
作者
Hauptmann, Susanne [1 ]
Keil, Uta
Scherping, Isabel
Bonert, Astrid
Eckert, Anne
Mueller, Walter E.
机构
[1] Goethe Univ Frankfurt, Dept Pharmacol, Bioctr, D-60439 Frankfurt, Germany
[2] Univ Basel, Psychiat Clin, Neurobiol Res Lab, CH-4025 Basel, Switzerland
关键词
Alzheimer's disease; mitochondrial dysfunction; beta-amyloid; neurofibrillary tangles;
D O I
10.1016/j.exger.2006.03.012
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Increasing evidence suggests an important role of mitochondrial dysfunction in the pathogenesis of many common age-related neurodegenerative diseases, including Alzheimer's disease (AD). AD is the most common neurodegenerative disorder characterized by dementia, memory loss, neuronal apoptosis and eventually death of the affected individuals. AD is characterized by two pathologic hallmark lesions that consist of extracellular plaques of amyloid-beta peptides and intracellular neurofibrillary tangles composed of hyperphosphorylated microtubular protein tau. Even though the idea that amyloid beta peptide accumulation is the primary event in the pathogenesis of Alzheimer's disease has become the leading hypothesis, the causal link between aberrant amyloid precursor protein and tau alterations in this type of dementia remains controversial. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:668 / 673
页数:6
相关论文
共 50 条
  • [31] Mitochondrial dysfunction and mitophagy failure in Alzheimer's disease
    Mary, Arnaud
    Vaillant-Beuchot, Loan
    Checler, Frederic
    Chami, Mounia
    M S-MEDECINE SCIENCES, 2021, 37 (10): : 843 - 847
  • [32] Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer's Disease
    Onukwufor, John O.
    Dirksen, Robert T.
    Wojtovich, Andrew P.
    ANTIOXIDANTS, 2022, 11 (04)
  • [33] Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?
    Bell, Simon M.
    Barnes, Katy
    De Marco, Matteo
    Shaw, Pamela J.
    Ferraiuolo, Laura
    Blackburn, Daniel J.
    Venneri, Annalena
    Mortiboys, Heather
    BIOMEDICINES, 2021, 9 (01) : 1 - 26
  • [34] Human fibroblasts from sporadic Alzheimer's disease (AD) patients show mitochondrial alterations and lysosome dysfunction
    Li, Yuan
    Li, Zhiquan
    Grillo, Emanuela
    Desler, Claus
    Navarro, Claudia
    Bohr, Vilhelm A.
    Berliocchi, Laura
    Rasmussen, Lene Juel
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 222 : 569 - 578
  • [35] Mitochondrial dysfunction and cellularmetabolic deficiency in Alzheimer's disease
    Xue-Mei Gu 1
    Neuroscience Bulletin, 2012, 28 (05) : 631 - 640
  • [36] Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease
    Cai, Qian
    Tammineni, Prasad
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1087 - 1103
  • [37] The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease
    Cheng, Ying
    Bai, Feng
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [38] Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease
    Gunter P. Eckert
    Kathrin Renner
    Schamim H. Eckert
    Janett Eckmann
    Stephanie Hagl
    Reham M. Abdel-Kader
    Christopher Kurz
    Kristina Leuner
    Walter E. Muller
    Molecular Neurobiology, 2012, 46 : 136 - 150
  • [39] Mitochondrial Dysfunction: Cause and Consequence of Alzheimer's Disease
    Friedland-Leuner, Kristina
    Stockburgert, Carola
    Denzer, Isabel
    Eckert, Gunter P.
    Mueller, Walter E.
    MITOCHONDRION IN AGING AND DISEASE, 2014, 127 : 183 - 210
  • [40] Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
    Moreira, Paula I.
    Carvalho, Cristina
    Zhu, Xiongwei
    Smith, Mark A.
    Perry, George
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (01): : 2 - 10